CFM
RVMD icon

Cornerstone Financial Management’s Revolution Medicines RVMD Stock Holding History

Cornerstone Financial Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.6K Buy
174
+3
+2% +$438 0.03% 190
2026
Q1 		$16.6K Buy
171
+161
+1,610% +$16.3K 0.02% 220
2025
Q4 		$797 Buy
+10
New +$656 ﹤0.01% 1004

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Cornerstone Financial Management's RVMD Position: Q2 2026 in Review

Cornerstone Financial Management increased its Revolution Medicines (RVMD) stake by 1.8% in Q2 2026, buying an estimated $438 and bringing the position to 174 shares worth $32.6K. The position accounts for 0.03% of the portfolio, ranked #190.

Cornerstone Financial Management first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Cornerstone Financial Management held 174 shares of Revolution Medicines worth $32.6K as of Q2 2026.
  • Cornerstone Financial Management bought 3 Revolution Medicines shares in Q2 2026, an estimated $438.
  • Revolution Medicines made up 0.03% of Cornerstone Financial Management's portfolio in Q2 2026, its #190 holding.
  • Cornerstone Financial Management first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.